eTMS for Veterans and First Responders with PTSD
This study is testing a treatment called Electroencephalogram personalized Transcranial Magnetic Stimulation (eTMS) for veterans and first responders who have Post-Traumatic Stress Disorder (PTSD). eTMS uses an EEG (a test that measures brain waves) to personalize how Transcranial Magnetic Stimulation (TMS) is applied to the front part of the brain. To join, you must be a veteran or first responder between 18 and 65 years old with a PTSD diagnosis. The study will look at how safe eTMS is and if it helps reduce PTSD symptoms. The current recruitment status is unclear.
- Study design
- This is a randomized, double-blind, sham-controlled study with two groups. It plans to include 20 participants.
- What's involved
- You will have two days of extensive testing before eTMS treatment and two days of testing after. This includes MRI, OPM, EEG, behavioral tasks, questionnaires, and an EEG sleep study.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your adverse events and symptoms will be measured for up to 7 weeks after treatment.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
eTMS for Veterans and First Responders With PTSD
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Wynn Legon, PhD · PRINCIPAL_INVESTIGATOR · Virginia Polytechnic Institute and State University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Adverse EventsUp to 7 weeks
Adverse event reports (or lack-of) will determine device safety
- Report of SymptomsUp to 7 weeks
Symptom questionnaire to be completed before and after all study procedures to determine feasibility in this patient population. Various symptoms will be rated on a likert scale from absent to severe.